219 related articles for article (PubMed ID: 33342034)
1. Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.
Tamura Y; Morikawa M; Tanabe R; Miyazono K; Koinuma D
Mol Oncol; 2021 May; 15(5):1289-1307. PubMed ID: 33342034
[TBL] [Abstract][Full Text] [Related]
2. PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer.
Tamura Y; Tsutsumi S; Miyazono K; Koinuma D
Cancer Sci; 2022 Mar; 113(3):940-949. PubMed ID: 34897916
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
4. Anticancer function of polyinosinic-polycytidylic acid.
Cheng YS; Xu F
Cancer Biol Ther; 2010 Dec; 10(12):1219-23. PubMed ID: 20930504
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer.
Yan H; Luo B; Wu X; Guan F; Yu X; Zhao L; Ke X; Wu J; Yuan J
Int J Biol Sci; 2021; 17(10):2606-2621. PubMed ID: 34326697
[TBL] [Abstract][Full Text] [Related]
6. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
7. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
8. Functional RIG-I-like receptors control the survival of mesenchymal stem cells.
Yang K; Wang J; Xiang AP; Zhan X; Wang Y; Wu M; Huang X
Cell Death Dis; 2013 Dec; 4(12):e967. PubMed ID: 24336087
[TBL] [Abstract][Full Text] [Related]
9. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
[TBL] [Abstract][Full Text] [Related]
10. Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3/GSDME in triple-negative breast cancer cells.
An H; Heo JS; Kim P; Lian Z; Lee S; Park J; Hong E; Pang K; Park Y; Ooshima A; Lee J; Son M; Park H; Wu Z; Park KS; Kim SJ; Bae I; Yang KM
Cell Death Dis; 2021 Feb; 12(2):159. PubMed ID: 33558527
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.
Tang X; Zhou Y; Liu Y; Zhang W; Liu C; Yan C
J Cell Biochem; 2020 Nov; 121(11):4642-4653. PubMed ID: 32048750
[TBL] [Abstract][Full Text] [Related]
12. Opposite actions of two dsRNA-binding proteins PACT and TRBP on RIG-I mediated signaling.
Vaughn LS; Chukwurah E; Patel RC
Biochem J; 2021 Feb; 478(3):493-510. PubMed ID: 33459340
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis.
Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J
Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170
[TBL] [Abstract][Full Text] [Related]
14. Regulation and function of the cytosolic viral RNA sensor RIG-I in pancreatic beta cells.
García M; Dogusan Z; Moore F; Sato S; Hartmann G; Eizirik DL; Rasschaert J
Biochim Biophys Acta; 2009 Nov; 1793(11):1768-75. PubMed ID: 19747951
[TBL] [Abstract][Full Text] [Related]
15. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
[TBL] [Abstract][Full Text] [Related]
16. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.
Taylor MA; Davuluri G; Parvani JG; Schiemann BJ; Wendt MK; Plow EF; Schiemann WP; Sossey-Alaoui K
Breast Cancer Res Treat; 2013 Nov; 142(2):341-53. PubMed ID: 24197660
[TBL] [Abstract][Full Text] [Related]
17. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
[TBL] [Abstract][Full Text] [Related]
18. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Cell Death Dis; 2013 Jan; 4(1):e479. PubMed ID: 23370279
[TBL] [Abstract][Full Text] [Related]
19. Metformin attenuates transforming growth factor beta (TGF-β) mediated oncogenesis in mesenchymal stem-like/claudin-low triple negative breast cancer.
Wahdan-Alaswad R; Harrell JC; Fan Z; Edgerton SM; Liu B; Thor AD
Cell Cycle; 2016; 15(8):1046-59. PubMed ID: 26919310
[TBL] [Abstract][Full Text] [Related]
20. Poly(I:C) exhibits an anti-cancer effect in human gastric adenocarcinoma cells which is dependent on RLRs.
Qu J; Hou Z; Han Q; Zhang C; Tian Z; Zhang J
Int Immunopharmacol; 2013 Nov; 17(3):814-20. PubMed ID: 24029594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
